|
|
1.
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. MedStar authors:
Year: 2022
Citation: - New England Journal of Medicine. 386(18):1700-1711, 2022 05 05.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Anjan S, Appel LJ, Baksh SN, Blair JE, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cluzet VC, Cordisco ME, Cruser D, Currier JS, Ehrhardt S, Ford DE, Forthal DN, Foster EC, Fukuta Y, Gawad AL, Gebo KA, Gerber JM, Gniadek TJ, Greenblatt B, Hammel J, Hammitt LL, Hanley DF, Heath SL, Huaman MA, Jabs DA, Karlen N, Kassaye SG, Klein SL, Laeyendecker O, Lane K, Lau B, Levine AC, Marshall CE, McBee NA, Meisenberg BR, Mosnaim GS, Oei K, Patel B, Paxton JH, Pekosz A, Petrini JR, Rausch W, Raval JS, Roth M, Shade DM, Shenoy AG, Shoham S, Singh A, Spivak ES, Sullivan DJ, Sutcliffe CG, Tobian AAR, Yarava A, Zand MS
|
|
|
2.
|
Early mortality benefit with COVID-19 convalescent plasma: a matched control study. MedStar authors:
- Baez, Valentina
- Blumenthal, Joseph
- Fernandez, Stephen J
- Hettinger, Aaron Z
- Shenoy, Aarthi G
Year: 2021
Citation: - British Journal of Haematology. 192(4):706-713, 2021 02.
Institution:
- MedStar Harbor Hospital
- MedStar Heart & Vascular Institute
- MedStar Institute for Innovation
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Emergency Medicine
- Medicine
Medline publication type:
All authors: - Baez V, Blumenthal J, Fernandez SJ, Hettinger AZ, Shenoy AG
|
